We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
REVIEW
Radiotherapy in the treatment of symptomatic vertebral hemangiomas: technical case report.
Neurosurgery 1996 November
OBJECTIVE AND IMPORTANCE: In contrast to the frequent finding of vertebral hemangiomas at autopsy and during radiographical examinations, symptomatic lesions are rare. In the literature, a variety of therapies and combinations of therapies have been reported. There is, however, significant inconsistency regarding which therapy is considered appropriate.
CLINICAL PRESENTATION: We report a young man with multiple vertebral hemangiomas, epidural extension, and secondary spastic paraparesis.
INTERVENTION: Rapid neurological deterioration and the clinical suspicion of malignant disease led to an initial decompressive laminectomy and biopsy of the intraspinal soft tissue lesion. Postoperative radiotherapy produced, however, substantial effects, with complete regression of the epidural hemangioma.
CONCLUSION: Based on the literature, we focus on diagnostic problems and choice of therapy for vertebral hemangiomas. Further, we discuss in particular the beneficial role of radiotherapy in the treatment of these nonmalignant lesions.
CLINICAL PRESENTATION: We report a young man with multiple vertebral hemangiomas, epidural extension, and secondary spastic paraparesis.
INTERVENTION: Rapid neurological deterioration and the clinical suspicion of malignant disease led to an initial decompressive laminectomy and biopsy of the intraspinal soft tissue lesion. Postoperative radiotherapy produced, however, substantial effects, with complete regression of the epidural hemangioma.
CONCLUSION: Based on the literature, we focus on diagnostic problems and choice of therapy for vertebral hemangiomas. Further, we discuss in particular the beneficial role of radiotherapy in the treatment of these nonmalignant lesions.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app